Immuron Stock
A loss of -2.610% shows a downward development for Immuron.
Criterium "EBIT Margin" is seen as the biggest plus for Immuron stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Immuron in the next few years
Pros
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Immuron vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Immuron | -2.610% | 3.704% | -4.274% | 28.736% | 34.132% | -51.515% | - |
| Stoke Therapeutics Inc | -1.720% | 4.717% | -11.200% | - | - | - | - |
| Personalis Inc | 2.200% | 6.105% | 7.433% | -33.799% | -33.990% | -93.296% | - |